NVCR NovoCure Limited gains 55% Mar 4, 2019
Markets a wearable electric field device for treating glioblastoma brain cancer.http://www.priceseries.com/trade/NVCR-NovoCure-Limited-stock-gains-55-percent-a-Trade-Record-by-priceSeries-2019010420190304.html